Navigating Challenges in Drug Discovery with Dr. Alfred Botchway

About this episode

Dr. Alfred Botchway discusses his journey in biomedical science and the role of AI in drug discovery.

In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Alfred Botchway, CEO of Attentive Science, to discuss his journey in biomedical science and the groundbreaking work being done at the intersection of AI, non-clinical safety, and drug discovery. Dr. Botchway shares his insights on the role of AI in refining toxicology studies, how stress impacts human health, and his experience founding companies like Xenometrics and Attentive Science. The conversation dives deep into the complexities of Good Laboratory Practices (GLP), the importance of regulatory standards, and the exciting research happening in anxiety and PTSD treatments. Dr. Botchway also discusses the future of biomedical research, the need for greater collaboration between academia and industry, and how innovations in sample collection are transforming clinical trials. Whether you’re interested in AI, biomedical innovation, or the future of drug discovery, this episode offers valuable insights from a leader shaping the industry. Don’t forget to subscribe and let us know your thoughts in the comments below! Dr. Alfred Botchway https://www.linkedin.com/in/alfred-botchway-41b01a6/ CEO…

People in this episode

Hosts: Dr. Chad Briscoe, Gregory Austin

Guest: Dr. Alfred Botchway

Topics covered

• drug discovery
• AI in biomedical science
• toxicology studies
• Good Laboratory Practices
• anxiety treatments
• PTSD research
• collaboration between academia and industry

Keywords

• drug discovery
• AI
• biomedical innovation
• toxicology
• Good Laboratory Practices
• anxiety
• PTSD
• clinical trials

Mentioned in this episode

Organizations: Attentive Science, Xenometrics, Celerion

More episodes of BioTalk Unzipped

• The Future of Oncology Drug Development | Dr. Lakshmi Amaravadi · June 11, 2026 · 30 min
• Active Machine Learning for Drug Discovery & Nanomedicine with Dr. Daniel Reker · April 25, 2026 · 51 min
• Why Haven’t We Cured Cancer Yet? | Dr. Bob Liu Explains · March 19, 2026 · 1h 0m
• The Intersection of Biotech, Patent Law, and AI with Dr. Kate Neville, IP Attorney · February 16, 2026 · 53 min
• Long-acting Cell-Based Gene Therapy, Fabry Disease and Beyond with Glafabra CEO, Dr. Chris Hopkins · December 22, 2025 · 49 min
• Fail Fast, Learn Faster: Drug Development in Rare Disease with Dr. Binodh DeSilva · October 23, 2025 · 31 min